Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Immunopharmacology and Immunotoxicology|January 24, 2014
Ginsenoside metabolite compound K attenuates inflammatory responses of adjuvant-induced arthritis ratsHuaxun Wu, Jingyu Chen, Qingtong Wang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 5, 2020
CP-25 alleviates antigen-induced experimental Sjögren's syndrome in mice by inhibiting JAK1-STAT1/2-CXCL13 signaling and interfering with B-cell migrationHuaxun Wu, Xiaoyun Chen, Fang Gu, et al.
International Immunopharmacology|November 9, 2025
CP-25 ameliorates dysfunction in the M3R-IP3R-Ca2+-AQP5 signaling pathway by inhibiting ERS in primary Sjögren's syndromeLei Huang, Yunxin Zhang, Fuxue Kuang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 4, 2022
Attenuation of experimental osteoarthritis with human adipose-derived mesenchymal stem cell therapy: inhibition of the pyroptosis in chondrocytesLiang Xu, Feng Zhang, Gang Cheng, et al.
Basic & Clinical Pharmacology & Toxicology|April 18, 2018
CP-25 Alleviates Experimental Sjögren's Syndrome Features in NOD/Ltj Mice and Modulates T Lymphocyte SubsetsFang Gu, Shixia Xu, Pengying Zhang, et al.
Experimental Cell Research|December 25, 2025
Targeting the Gas6-TAM-SOCS1/3 axis: CP-25 attenuates macrophage dysfunction in primary Sjögren's syndromeYun Chen, Qianwen Tian, Meng Yang, et al.
Rheumatology (Oxford, England)|December 28, 2010
Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responsesYan Chang, Yujing Wu, Di Wang, et al.
Inflammation|April 17, 2014
Ginsenoside metabolite compound k alleviates adjuvant-induced arthritis by suppressing T cell activationJingyu Chen, Huaxun Wu, Qingtong Wang, et al.
Pageof 5